Rule 2.9 Announcement

Summary by AI BETAClose X

Advanced Medical Solutions confirms it has 221,193,292 ordinary shares of 5 pence each in issue and admitted to trading, with no shares held in treasury, so the total number of shares with full voting rights is 221,193,292; under the Code a holder acquiring 1% or more must make an Opening Position Disclosure by no later than 3.30pm (London time) on the tenth business day following commencement of the offer period, and Dealing Disclosures must be made by 3.30pm on the business day after any relevant dealing.

Disclaimer*

UK 100

Latest directors dealings